About Zydus Lifesciences Limited
Zydus Lifesciences Limited (ZYDUSLIFE) has been publicly traded since 2000, making it a 26-year-old public company. It operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. The company is headquartered in Ahmedabad, India and employs approximately 27,917 people. With a market capitalization of $912 billion, ZYDUSLIFE is one of the largest publicly traded companies.
Key Statistics
- Current Price
- ₹905.90
- Market Cap
- ₹911.85B
- 52-Week High
- ₹1,059.05
- 52-Week Low
- ₹795.00
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
₹1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -0.92% | ₹914.35 | ₹905.90 |
| 2025 | -4.82% | ₹960.69 | ₹914.35 |
| 2024 | +41.34% | ₹679.70 | ₹960.69 |
| 2023 | +65.64% | ₹410.33 | ₹679.70 |
| 2022 | -12.46% | ₹468.73 | ₹410.33 |
| 2021 | +1.94% | ₹459.82 | ₹468.73 |
| 2020 | +89.80% | ₹242.26 | ₹459.82 |
| 2019 | -25.89% | ₹326.90 | ₹242.26 |
| 2018 | -18.88% | ₹402.97 | ₹326.90 |
| 2017 | +22.42% | ₹329.17 | ₹402.97 |
| 2016 | +9.92% | ₹299.45 | ₹329.17 |
| 2015 | +3.04% | ₹290.63 | ₹299.45 |
| 2014 | +99.10% | ₹145.97 | ₹290.63 |
| 2013 | -9.29% | ₹160.93 | ₹145.97 |
| 2012 | +29.18% | ₹124.58 | ₹160.93 |
| 2011 | -8.83% | ₹136.65 | ₹124.58 |
| 2010 | +80.76% | ₹75.60 | ₹136.65 |
| 2009 | +146.75% | ₹30.64 | ₹75.60 |
| 2008 | -7.05% | ₹32.96 | ₹30.64 |
| 2007 | -9.07% | ₹36.25 | ₹32.96 |
| 2006 | -28.21% | ₹50.49 | ₹36.25 |
| 2005 | -15.48% | ₹59.74 | ₹50.49 |
| 2004 | +54.46% | ₹38.67 | ₹59.74 |
| 2003 | +226.52% | ₹11.84 | ₹38.67 |
| 2002 | -3.21% | ₹12.24 | ₹11.84 |
| 2001 | -16.14% | ₹14.59 | ₹12.24 |
Valuation
ZYDUSLIFE currently trades at a trailing P/E ratio of 18.5, which is considered moderate relative to the broader market. The forward P/E of 21.8 suggests analysts expect earnings to be higher in the coming year. The price-to-book ratio stands at 3.6. The price-to-sales ratio is 3.5.
Dividends
Zydus Lifesciences Limited pays a dividend to shareholders with a current yield of 1.21%. This translates to $11.00 per share annually. The payout ratio of 22% indicates sustainable dividend coverage.
Risk & Volatility
ZYDUSLIFE has a beta of 0.37, indicating it is less volatile than the overall market. The stock's 52-week range is $795.00 to $1059.05, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 30 analyst opinions, ZYDUSLIFE has a consensus "hold" rating. The average price target of $993.73 suggests 9.7% upside from current levels.
Frequently Asked Questions
What does Zydus Lifesciences Limited do? ▼
Zydus Lifesciences Limited is a Drug Manufacturers - Specialty & Generic company operating in the Healthcare sector. The company is headquartered in Ahmedabad, India.
What sector is ZYDUSLIFE in? ▼
ZYDUSLIFE operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
When did ZYDUSLIFE go public? ▼
Zydus Lifesciences Limited went public in 2000, making it a 26-year-old public company as of 2026.
How much would $1,000 invested in ZYDUSLIFE 5 years ago be worth today? ▼
A $1,000 investment in ZYDUSLIFE five years ago would be worth approximately $2,008 today, representing a 100.8% return.
Does ZYDUSLIFE pay dividends? ▼
Yes, Zydus Lifesciences Limited pays a dividend with a current yield of 1.21%, which is $11.0 per share annually.
What is ZYDUSLIFE's market cap? ▼
Zydus Lifesciences Limited has a market capitalization of $912 billion, classifying it as a mega-cap company.
What is ZYDUSLIFE's P/E ratio? ▼
ZYDUSLIFE has a trailing P/E ratio of 18.5 and a forward P/E of 21.8, which measures how much investors are paying per dollar of earnings.
Is ZYDUSLIFE a buy, hold, or sell? ▼
Based on 30 opinions, ZYDUSLIFE has a consensus "hold" rating. The average price target is $993.73.
Last updated: 3/14/2026